Compare Natera Inc. Common Stock (NTRA) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Sirius XM Holdings Inc — how do they compare? Natera Inc. Common Stock trades at $393.93 (market cap $57.03B), while Sirius XM Holdings Inc trades at $26.42 (market cap $8.94B). The key difference: Natera Inc. Common Stock is far larger — about 6.4× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays a 4.07% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Sirius XM Holdings Inc for 103 Days on average.
| NTRA | SIRI | |
|---|---|---|
Market Cap | $57.03B | $8.94B |
Volume | 1,131,157 | 2,400,454 |
Sector | Health | Media |
52-Week High | $425.64 | $32.59 |
52-Week Low | $179.42 | $19.92 |
Typical Hold Time | 0 Days | 103 Days |
Enterprise Value | $56.18B | $18.22B |
Dividend Yield | — | 4.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Sirius XM (SIRI) trades at $26.57, down slightly by 0.15% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net income margin of 10.23% for 2025, with revenue of $8.56B, and maintains a dividend payout. Recent news highlights a 53% YTD stock surge and positive analyst upgrades driven by advertising growth and a strategic YouTube partnership.
The outlook is cautiously optimistic, supported by strong analyst buy ratings (62.5%) and a consensus price target of $34.43, implying significant upside. Key risks include recent earnings misses, high debt levels, and competitive pressures in the media sector. Cash flow trends show improvement, with net cash flow turning positive in 2026 projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
